EP0215059A4 - C-dna, kodierend für plasmodium-falciparum-glykophorinbindungsproteine mit einem gewicht von 130000 dalton bzw 155000 dalton. - Google Patents

C-dna, kodierend für plasmodium-falciparum-glykophorinbindungsproteine mit einem gewicht von 130000 dalton bzw 155000 dalton.

Info

Publication number
EP0215059A4
EP0215059A4 EP19860901657 EP86901657A EP0215059A4 EP 0215059 A4 EP0215059 A4 EP 0215059A4 EP 19860901657 EP19860901657 EP 19860901657 EP 86901657 A EP86901657 A EP 86901657A EP 0215059 A4 EP0215059 A4 EP 0215059A4
Authority
EP
European Patent Office
Prior art keywords
daltons
binding proteins
plasmodium falciparum
cdna coding
glycophorin binding
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP19860901657
Other languages
English (en)
French (fr)
Other versions
EP0215059A1 (de
Inventor
Jeffrey V Ravetch
Margaret E Perkins
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Rockefeller University
Memorial Sloan Kettering Cancer Center
Original Assignee
Sloan Kettering Institute for Cancer Research
Rockefeller University
Memorial Sloan Kettering Cancer Center
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sloan Kettering Institute for Cancer Research, Rockefeller University, Memorial Sloan Kettering Cancer Center filed Critical Sloan Kettering Institute for Cancer Research
Publication of EP0215059A1 publication Critical patent/EP0215059A1/de
Publication of EP0215059A4 publication Critical patent/EP0215059A4/de
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • C07K14/445—Plasmodium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
EP19860901657 1985-02-20 1986-02-19 C-dna, kodierend für plasmodium-falciparum-glykophorinbindungsproteine mit einem gewicht von 130000 dalton bzw 155000 dalton. Withdrawn EP0215059A4 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US70351985A 1985-02-20 1985-02-20
US703519 1985-02-20

Publications (2)

Publication Number Publication Date
EP0215059A1 EP0215059A1 (de) 1987-03-25
EP0215059A4 true EP0215059A4 (de) 1988-04-13

Family

ID=24825702

Family Applications (1)

Application Number Title Priority Date Filing Date
EP19860901657 Withdrawn EP0215059A4 (de) 1985-02-20 1986-02-19 C-dna, kodierend für plasmodium-falciparum-glykophorinbindungsproteine mit einem gewicht von 130000 dalton bzw 155000 dalton.

Country Status (4)

Country Link
EP (1) EP0215059A4 (de)
JP (1) JPS62502933A (de)
AU (1) AU5540886A (de)
WO (1) WO1986004922A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL76338A (en) * 1984-09-11 1994-08-26 Saramane Pty Ltd Plasmodium plasmodium immunogenic polypeptides, AND molecules encoding them, a method for preparing the polypeptides and preparations containing the polypeptide
WO1988000595A1 (en) * 1986-07-17 1988-01-28 Saramane Pty. Ltd. Merozoite surface antigen of plasmodium falciparum
DE3741057A1 (de) * 1987-03-18 1988-09-29 Behringwerke Ag Klonierung von malaria-spezifischen dna-sequenzen:isolierung des gens fuer das 140 kd protein
US5225534A (en) * 1987-09-08 1993-07-06 Hoffmann-La Roche Inc. Recombinant malarial polypeptides
EP0309746A1 (de) * 1987-09-08 1989-04-05 F. Hoffmann-La Roche Ag Antimalaria-Vakzine
DE4105348A1 (de) * 1991-02-21 1992-09-03 Behringwerke Ag Ein plasmodium falciparum blutstadien-antigen, seine herstellung und verwendung

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1984002917A1 (en) * 1983-01-28 1984-08-02 Inst Medical W & E Hall EXPRESSION OF PLASMODIUM FALCIPARUM POLYPEPTIDES FROM CLONED cDNA

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4466917A (en) * 1981-02-12 1984-08-21 New York University Malaria vaccine

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1984002917A1 (en) * 1983-01-28 1984-08-02 Inst Medical W & E Hall EXPRESSION OF PLASMODIUM FALCIPARUM POLYPEPTIDES FROM CLONED cDNA

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
NATURE, vol. 310, 30th August 1984, pages 789-792; R.L. COPPEL et al.: "Immune sera recognize on erythrocytes a Plasmodium falciparum antigen composed of repeated amino acid sequences" *
PROC. NATL. ACAD. SCI. USA, vol. 81, December 1984, pages 7912-7916; B. WAHLIN et al.: "Human antibodies to a Mr 155,000 Plasmodium falciparum antigen efficiently inhibit merozoite invasion" *
PROC. NATL. ACAD. SCI. USA, vol. 82, January 1985, pages 543-547; H.-D. STAHL et al.: "Interspersed blocks of repetitive and charged amino acids in a dominant immunogen of Plasmodium falciparum" *
SCIENCE, vol. 227, no. 4694, 29th March 1985, pages 1593-1597; J.V. RAVETCH et al.: "Isolation of the gene for a glycophorin-binding protein implicated in erythrocyte invasion by a malaria parasite" *
See also references of WO8604922A1 *

Also Published As

Publication number Publication date
WO1986004922A1 (en) 1986-08-28
EP0215059A1 (de) 1987-03-25
JPS62502933A (ja) 1987-11-26
AU5540886A (en) 1986-09-10

Similar Documents

Publication Publication Date Title
EP0199991A3 (en) Fluoropolymer alloys, their preparation and application
EP0208421A3 (en) Fluoropolymer compositions, their preparation and use
GB8615999D0 (en) Platinum alloy electrocatalyst
IL78315A0 (en) Perfluoroalkanes and haloperfluoroalkanes,and their preparation
GB9012214D0 (en) Albased alloy
GB8705909D0 (en) Sintered alloy
EP0162699A3 (en) Interleukin-2 receptor and dna encoded therefor and their preparation
GB2203740B (en) Novel peptides, their preparation and use
GB8602679D0 (en) Alloy
EP0279459A3 (en) Anticoagulant polypeptide
GB8610230D0 (en) Dna segment coding
EP0215059A4 (de) C-dna, kodierend für plasmodium-falciparum-glykophorinbindungsproteine mit einem gewicht von 130000 dalton bzw 155000 dalton.
GB2184457B (en) Gold alloy
IL81026A0 (en) Peptides for immunizing against plasmodium falciparum,dna molecules coding for them and compositions containing said peptides
GR860237B (en) Gold alloy
PH22377A (en) 5-aryl-2,4-diakyl-3h-1,2,4-triazole-3-thiones and their use as anti-depressant
GB2218109B (en) Semi-bright watchcase and method for the preparation thereof
IL87779A0 (en) 4-azasaccharines,4-aza-dihydro-and-tetrahydro-saccharines and their preparation
JPS6490223A (en) Film from aromatic copolyamide, manufacture and use
EP0286114A3 (en) Reg gene and protein encoded by the gene
GB2198746B (en) Sulfidation-resistant alloy
GR910300040T1 (en) Coding terminal
EP0288901A3 (en) Recombinant human glutathione peroxidase, process for preparing the same and dna coding the same
ZA889506B (en) Soluble recombinant fce-receptor,the preparation and the use thereof
CS471287A1 (en) Elektronicky ridici obvod pro ovladani elektrodynamickych brzdicek textilnich niti

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE FR GB IT LI LU NL SE

17P Request for examination filed

Effective date: 19870105

A4 Supplementary search report drawn up and despatched

Effective date: 19880413

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 19900901

RIN1 Information on inventor provided before grant (corrected)

Inventor name: PERKINS, MARGARET, E.

Inventor name: RAVETCH, JEFFREY, V.